November 19, 2020

Pfizer/BioNTech to seek emergency vaccine approval in US Friday

Washington (AFP) – An emergency use authorization request for the Covid-19 vaccine developed by Pfizer and BioNTech was expected to be filed with the FDA on Friday, the US government and BioNTech’s co-founder said.This type of Food and Drug Administration authorization is temporary or conditional and is granted in response to an emergency situation such as a pandemic.”Pfizer’s partner BioNTech has announced that tomorrow they intend to file for emergency use authorization at the FDA,” health secretary Alex Azar told a press conference Thursday in Washington.BioNTech co-founder Ugur Sahin earli…


Leave a Reply

Your email address will not be published. Required fields are marked *